Company: RGNT
Filing Date: 2025-03-11
Form Type: F-1
Source: 0001213900-25-022350
Chunk: 152

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-03-11
Form: F-1
Chunk 152
---
 time of the registration statement to which this prospectus relates. Mr. Cohen-Arazi was the
Co-Founder & Chief Executive Officer of Rainbow Medical, a leading Israeli medical device innovation house since 2008. From 2004
to 2006 Mr. Cohen-Arazi served as the Chief Executive Officer and Co-Founder of IntecPharma Ltd. and as Chairman of CollPlant Ltd. since
2006. Mr. Cohen-Arazi served as a director in numerous biotech/medtech companies since 2005, and currently serves as a director in PainReform
Ltd. (NASDAQ: PRFX). Mr. Cohen-Arazi was the Senior VP Head of Operations at Immunex Corporation in Seattle, Washington until 2002 when
it was acquired by Amgen, where he served as VP and General Manager of the TO site in California. Mr. Cohen Arazi served at Merck-Serono
Group in Switzerland and Israel between 1988 and 2000. Mr. Cohen-Arazi received a M.Sc. degree from the Hebrew University of Jerusalem,
Israel.

<div align='center'>91</div>

Mr. Pini Ben-Elazar, Director Nominee

Mr. Ben-Elazar will become
our director at the effective time of the registration statement to which this prospectus relates, and will serve as an External Director
under the Companies Law for a 3-year term. Mr. ben-Elazar is a very experienced executive as a Chief Executive Officer and as a director
with over 25 years of successful experience in the healthcare industry. He is a change and growth leader providing fiscal, strategic
and operations leadership in uniquely challenging situations, and is a professional negotiator harnessing effective and creative thinking
and communicating skills. Mr Ben-Elazar currently serves as the Chief Executive Officer of Mor Research Applications, Tech Transfer Office
of Clalit Health Services in Israel since 2003. He is also a director in numerous healthcare companies among them: Ceretrieve, Enox,
DreamMed Diabetes, Data2Life, NGS, APX ophthalmology, Zebra Medical Vision, and Galil Ofek. Mr. Ben-Elazar holds an MBA from Johnson
& Wales University, Providence, RI since 1996, a B.Sc in Hospitality Management, Johnson & Wales University, Providence, RI,
and completed the studies of the 8400 Health Network Leadership Program, Harvard Business School, in 2019.

Dr.